Alaunos Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
4.05
|
|
Average Rating
|
4.17
|
|
# Strong Buys
|
3
|
|
# Buys
|
1
|
|
# Holds
|
2
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.08
|
-0.04
|
0.04
|
50.00%
|
|
2022-06-30
|
-0.07
|
-0.05
|
0.02
|
28.57%
|
|
2022-03-31
|
-0.07
|
-0.05
|
0.02
|
28.57%
|
|
2021-12-31
|
-0.08
|
-0.05
|
0.03
|
37.50%
|
|
2021-09-30
|
-0.13
|
-0.11
|
0.02
|
15.38%
|
|
2021-06-30
|
-0.12
|
-0.11
|
0.01
|
8.33%
|
|
2021-03-31
|
-0.10
|
-0.10
|
0.00
|
0.00%
|
|
2020-12-31
|
-0.10
|
-0.11
|
-0.01
|
-10.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.14
|
|
2021-12-31
|
-0.37
|
|
2020-12-31
|
-0.39
|
|
2019-12-31
|
-0.69
|
|
2018-12-31
|
0.89
|
|
2017-12-31
|
-0.54
|
|
2016-12-31
|
-1.32
|
|
2015-12-31
|
-0.42
|
|
2014-12-31
|
-0.31
|
|
2013-12-31
|
-0.66
|
|
2012-12-31
|
-1.22
|
|
2011-12-31
|
-1.01
|
|
2010-12-31
|
-0.76
|
|
2009-12-31
|
-0.54
|
|
2008-12-31
|
-1.19
|
|
2007-12-31
|
-1.31
|
|
2006-12-31
|
-1.48
|
|
2005-12-31
|
-91.25
|